Bettina A. Hamelin

3.6k total citations
57 papers, 2.9k citations indexed

About

Bettina A. Hamelin is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Bettina A. Hamelin has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Bettina A. Hamelin's work include Pharmacogenetics and Drug Metabolism (14 papers), Gastroesophageal reflux and treatments (7 papers) and Eosinophilic Esophagitis (7 papers). Bettina A. Hamelin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Gastroesophageal reflux and treatments (7 papers) and Eosinophilic Esophagitis (7 papers). Bettina A. Hamelin collaborates with scholars based in Canada, United States and France. Bettina A. Hamelin's co-authors include Jacques Turgeon, Benoît Drolet, J. P. Galmiche, Philippe Barthélémy, Ashish Sharma, Étienne Lessard, Gilles O’Hara, Donald J. D’Amico, David A. Johnson and Claude J. Allègre and has published in prestigious journals such as Circulation, Earth and Planetary Science Letters and Clinical Cancer Research.

In The Last Decade

Bettina A. Hamelin

56 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bettina A. Hamelin Canada 25 853 614 610 535 436 57 2.9k
Kyoichi Ohashi Japan 31 1.3k 1.5× 946 1.5× 773 1.3× 420 0.8× 305 0.7× 156 3.3k
Hirotoshi Echizen Japan 28 432 0.5× 311 0.5× 1.2k 2.0× 373 0.7× 387 0.9× 100 3.0k
Kazuko Nakagawa Japan 32 454 0.5× 249 0.4× 620 1.0× 588 1.1× 216 0.5× 117 2.8k
Sandra Close United States 17 1.7k 2.0× 179 0.3× 618 1.0× 306 0.6× 931 2.1× 39 4.7k
Micha Levy Israel 31 556 0.7× 108 0.2× 283 0.5× 1.4k 2.6× 494 1.1× 51 3.5k
Henning Blume Germany 25 209 0.2× 252 0.4× 278 0.5× 338 0.6× 215 0.5× 89 2.1k
Karl Zech Germany 30 242 0.3× 158 0.3× 475 0.8× 636 1.2× 225 0.5× 100 2.5k
Joyce Blaisdell United States 30 537 0.6× 290 0.5× 2.8k 4.6× 908 1.7× 651 1.5× 35 4.4k
John J. Lima United States 33 585 0.7× 319 0.5× 479 0.8× 522 1.0× 221 0.5× 128 3.6k
Céline Verstuyft France 36 851 1.0× 107 0.2× 1.2k 2.0× 487 0.9× 806 1.8× 131 4.8k

Countries citing papers authored by Bettina A. Hamelin

Since Specialization
Citations

This map shows the geographic impact of Bettina A. Hamelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina A. Hamelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina A. Hamelin more than expected).

Fields of papers citing papers by Bettina A. Hamelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina A. Hamelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina A. Hamelin. The network helps show where Bettina A. Hamelin may publish in the future.

Co-authorship network of co-authors of Bettina A. Hamelin

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina A. Hamelin. A scholar is included among the top collaborators of Bettina A. Hamelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina A. Hamelin. Bettina A. Hamelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamelin, Bettina A., et al.. (2010). Increased Risk of Myocardial Infarction Associated With Angiotensin-Converting Enzyme Gene Polymorphism Is Age Dependent. The Journal of Clinical Pharmacology. 51(9). 1286–1292. 20 indexed citations
2.
Sharma, Ashish, Philippe Pîbarot, Sylvie Pilote, et al.. (2009). Toward Optimal Treatment in Women: The Effect of Sex on Metoprolol‐Diphenhydramine Interaction. The Journal of Clinical Pharmacology. 50(2). 214–225. 21 indexed citations
3.
Méthot, Julie, Bettina A. Hamelin, Marie Arsenault, et al.. (2006). The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women. Menopause The Journal of The North American Menopause Society. 13(6). 959–966. 12 indexed citations
4.
Caron, Étienne, et al.. (2006). Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCR. Journal of Biochemical and Molecular Toxicology. 19(6). 368–378. 34 indexed citations
5.
Méthot, Julie, Bettina A. Hamelin, Peter Bogaty, et al.. (2005). ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women. International Journal of Cardiology. 105(3). 308–314. 12 indexed citations
6.
Sharma, Ashish, Sylvie Pilote, P M Bélanger, Marie Arsenault, & Bettina A. Hamelin. (2004). A convenient five‐drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study. British Journal of Clinical Pharmacology. 58(3). 288–297. 32 indexed citations
7.
Lessard, Étienne, Marie‐Andrée Yessine, Bettina A. Hamelin, et al.. (2001). Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans. Journal of Clinical Psychopharmacology. 21(2). 175–184. 57 indexed citations
8.
Labbé, Line, Caroline Sirois, Sylvie Pilote, et al.. (2000). Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.. Pharmacogenetics. 10(5). 425–438. 89 indexed citations
9.
10.
Lessard, Étienne, et al.. (1999). Involvement of CYP2D6 activity in the N-oxidation of procainamide in man. Pharmacogenetics and Genomics. 9(6). 683–696. 34 indexed citations
11.
12.
Galmiche, J. P., Philippe Barthélémy, & Bettina A. Hamelin. (1997). Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride. Alimentary Pharmacology & Therapeutics. 11(4). 765–773. 169 indexed citations
13.
Bergmann, Jean‐François, et al.. (1995). [Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].. PubMed. 19(5). 482–6. 3 indexed citations
14.
Hamelin, Bettina A., et al.. (1994). Caffeine metabolism in cystic fibrosis: Enhanced xanthine oxidase activity. Clinical Pharmacology & Therapeutics. 56(5). 521–529. 20 indexed citations
15.
Barbier, J, et al.. (1993). Facteurs pronostiques de la cicatrisation de l'oesophagite par reflux. Un essai controôlé oméprazole versus ranitidine. Groupe d'Etude Omega.. 29(4). 1 indexed citations
16.
Hamelin, Bettina A., et al.. (1993). Cefepime Pharmacokinetics in Cystic Fibrosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(5). 465–470. 14 indexed citations
17.
Bour, Bruno, et al.. (1993). Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.. PubMed. 17(5). 329–33. 13 indexed citations
18.
Hamelin, Bettina A., et al.. (1991). [Angiodysplasia of the small intestine. Surgical resection guided by peroperative enteroscopy].. PubMed. 128(11). 500–1. 1 indexed citations
19.
Nalpas, Bertrand, F. Driss, Stanislas Pol, et al.. (1991). Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. Journal of Hepatology. 12(1). 70–74. 110 indexed citations
20.
Hamelin, Bettina A. & Claude J. Allègre. (1988). Lead isotope study of orogenic lherzolite massifs. Earth and Planetary Science Letters. 91(1-2). 117–131. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyoichi Ohashi Breakdown of academic impact, for papers by Hirotoshi Echizen Breakdown of academic impact, for papers by Kazuko Nakagawa Breakdown of academic impact, for papers by Sandra Close Breakdown of academic impact, for papers by Micha Levy Breakdown of academic impact, for papers by Henning Blume Breakdown of academic impact, for papers by Karl Zech Breakdown of academic impact, for papers by Joyce Blaisdell Breakdown of academic impact, for papers by John J. Lima Breakdown of academic impact, for papers by Céline Verstuyft
Rankless by CCL
2026